Power Law company profile

AC Immune

Biotech & Life Sciences · Lausanne, Switzerland · Founded 2003 · IPO 2016 Thoroughbred

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$188M

Market cap · Apr/2026

Revenue

$3.3M

Latest reported FY

Investors

3 investors on AC Immune's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series B+ 3 investors entered at this stage

Global footprint

AI talent share

1.4% of workforce is AI talent
(2 of 145 staff)

Core AI21.38%

Other AI00%

Non-AI workforce14398.62%

Web traffic by country

7.5K monthly visits
across markets

🇺🇸 United States44%

🇬🇧 United Kingdom14.7%

🇨🇭 Switzerland12%

🇮🇳 India10.7%

🇫🇷 France6.7%

Top 5 markets shown

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo